Intellectual Property India Publishes Patent Application for 'Compositions And Methods For Inhibition Of Expression Of Inhibin Subunit Beta E (INHBE) Genes' Filed by Basecure Therapeutics Llc

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202547096953 A) filed by Basecure Therapeutics Llc, Dover, U.S.A., on Oct. 8, for 'compositions and methods for inhibition of expression of inhibin subunit beta e (inhbe) genes.'

Inventor(s) include Yang, Jing; Kim. Kevin J; and Montero, Saul Martinez.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to double-stranded ribonucleic acid (dsRNA) targeting an INHBE gene, and methods of using the dsRNA to inhibit expression of INHBE."

The patent application was internationally filed on Mar. 11, 2024, under International application No.PCT/US2024/019416.

Disclaimer: Curated by HT Syndication.